ANTI-AQUAPORIN-4 / NMO ANTIBODIES ( NEUROMYELITIS OPTICA ANTIBODIES)

The Anti-Aquaporin-4 (AQP4) / Neuromyelitis Optica (NMO) Antibodies Test is a specialized blood test that detects autoantibodies against Aquaporin-4 (AQP4), a water channel protein found on astrocytes within the central nervous system (CNS). These antibodies are highly specific for Neuromyelitis Optica Spectrum Disorder (NMOSD), a rare autoimmune neurological disease affecting the optic nerves, spinal cord, and, in some cases, parts of the brain.

In NMOSD, the immune system mistakenly attacks Aquaporin-4 proteins, causing inflammation and damage to the optic nerves and spinal cord. This may lead to episodes of optic neuritis, transverse myelitis, vision loss, limb weakness, numbness, bladder dysfunction, and paralysis. Early diagnosis is essential because NMOSD requires treatment that differs from multiple sclerosis (MS), and prompt therapy can reduce relapses and permanent neurological disability.

The Anti-AQP4 Antibody Test is considered the gold standard serological test for diagnosing NMOSD. It is commonly performed in patients presenting with recurrent optic neuritis, longitudinally extensive transverse myelitis, unexplained neurological symptoms, or when NMOSD is suspected clinically.

This test is often interpreted together with MRI of the brain and spinal cord, cerebrospinal fluid (CSF) analysis, neurological examination, and Myelin Oligodendrocyte Glycoprotein (MOG) antibody testing to establish an accurate diagnosis.

Benefits of the Test

• Detects Anti-Aquaporin-4 (AQP4) antibodies with high specificity
• Helps diagnose Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Differentiates NMOSD from multiple sclerosis (MS)
• Supports early diagnosis and timely treatment
• Assists neurologists in treatment planning
• Helps reduce the risk of recurrent neurological attacks
• Requires only a peripheral blood sample

Why Doctors Recommend This Test

Doctors may recommend this test if a patient has:

• Sudden vision loss or optic neuritis
• Recurrent episodes of optic neuritis
• Weakness or paralysis of the limbs
• Numbness or tingling sensations
• Transverse myelitis
• Difficulty walking
• Bladder or bowel dysfunction
• Persistent neurological symptoms
• Suspected Neuromyelitis Optica Spectrum Disorder
• Unexplained spinal cord inflammation

Preparation Before Test

Sample Required

• Peripheral venous blood sample (Serum)

Preparation Guidelines

• No fasting is generally required.
• Continue prescribed medications unless advised otherwise by your physician.
• Inform your healthcare provider about previous neurological illnesses, autoimmune diseases, and current medications.
• Follow laboratory instructions before sample collection.

Reporting Time

Results are generally available within 5–10 working days, depending on laboratory methodology.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Patients with recurrent optic neuritis
• Individuals with transverse myelitis
• Patients with unexplained neurological symptoms
• Individuals requiring differentiation between NMOSD and multiple sclerosis
• Patients referred by neurologists or neuroimmunology specialists

Clinical Significance

A positive Anti-Aquaporin-4 (AQP4) antibody result may indicate:

• Neuromyelitis Optica Spectrum Disorder (NMOSD)
• Neuromyelitis Optica (NMO)
• Autoimmune Demyelinating Disease
• Autoimmune Central Nervous System Disorder

Common symptoms associated with NMOSD include:

• Vision loss
• Eye pain
• Optic neuritis
• Limb weakness
• Paralysis
• Numbness or tingling
• Difficulty walking
• Bladder dysfunction
• Bowel dysfunction
• Persistent neurological disability

A positive Anti-AQP4 antibody result strongly supports the diagnosis of NMOSD. However, results should always be interpreted alongside neurological examination, MRI findings, cerebrospinal fluid (CSF) analysis, MOG antibody testing, and other relevant clinical investigations.